Lipocalin-type prostaglandin D2 synthase stimulates glucose transport via enhanced GLUT4 translocation

Prostaglandins and Other Lipid Mediators

Volumn 87, Issue 1-4, 2008, Pages 34-41

  Ragolia, Louis ^a,b   Hall, Christopher E ^a   Palaia, Thomas ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Adipose; Diabetes; Glucose transport; Insulin resistance; Muscle; Prostaglandin

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; HEXOKINASE; INSULIN; LIPOCALIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN D2 SYNTHASE; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG; WORTMANNIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GENE EXPRESSION; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HYPERGLYCEMIA; INSULIN RESISTANCE; KNOCKOUT MOUSE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; DIABETES MELLITUS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HYPERGLYCEMIA; INSULIN; INTRAMOLECULAR OXIDOREDUCTASES; LIPOCALINS; MALE; MICE; MICE, KNOCKOUT; MUSCLES; PROSTAGLANDIN D2; RATS; SIGNAL TRANSDUCTION;

EID: 55549121198     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2008.06.001     Document Type: Article

References (42)

1. Watson R.T., and Pessin J.E. Bridging the GAP between insulin signaling and GLUT4 translocation. Trends Biochem Sci 31 April (4) (2006) 215-222
2. Urade Y., and Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm 58 (2000) 89-120
3. Taba Y., Sasaguri T., Miyagi M., et al. Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells. Circ Res 86 May (9) (2000) 967-973
4. Rogers M.S., Rohan R.M., Birsner A.E., and D'Amato R.J. Genetic loci that control vascular endothelial growth factor-induced angiogenesis. FASEB J September (2003)
5. Ragolia L., Palaia T., Paric E., and Maesaka J.K. Prostaglandin D2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells. J Biol Chem 278 June (24) (2003) 22175-22181
6. Ragolia L., Palaia T., Koutrouby T.B., and Maesaka J.K. Inhibition of cell cycle progression and migration of vascular smooth muscle cells by prostaglandin D2 synthase: resistance in diabetic Goto-Kakizaki rats. Am J Physiol Cell Physiol 287 November (5) (2004) C1273-C1281
7. Otsuki M., Gao H., Dahlman-Wright K., et al. Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta. Mol Endocrinol 17 September (9) (2003) 1844-1855
8. Miwa Y., Takiuchi S., Kamide K., et al. Identification of gene polymorphism in lipocalin-type prostaglandin D synthase and its association with carotid atherosclerosis in Japanese hypertensive patients. Biochem Biophys Res Commun 322 September (2) (2004) 428-433
9. Inoue T., Takayanagi K., Morooka S., et al. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. Thromb Haemost 85 January (1) (2001) 165-170
10. Hirawa N., Uehara Y., Yamakado M., et al. Lipocalin-type prostaglandin d synthase in essential hypertension. Hypertension 39 February (2 Pt 2) (2002) 449-454
11. Eguchi Y., Eguchi N., Oda H., et al. Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA 94 December (26) (1997) 14689-14694
12. Whittle B.J., Moncada S., and Vane J.R. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins 16 September (3) (1978) 373-388
13. Sasaguri T., and Miwa Y. Prostaglandin J2 family and the cardiovascular system. Curr Vasc Pharmacol 2 April (2) (2004) 103-114
14. Braun M., and Schror K. Prostaglandin D2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. Circ Res 71 December (6) (1992) 1305-1313
15. Hiraoka A., Seiki K., Oda H., et al. Charge microheterogeneity of the beta-trace proteins (lipocalin-type prostaglandin D synthase) in the cerebrospinal fluid of patients with neurological disorders analyzed by capillary isoelectrofocusing. Electrophoresis 22 October (16) (2001) 3433-3437
16. Lescuyer P., Gandini A., Burkhard P.R., Hochstrasser D.F., and Sanchez J.C. Prostaglandin D2 synthase and its post-translational modifications in neurological disorders. Electrophoresis 26 December (23) (2005) 4563-4570
17. Melegos D.N., Freedman M.S., and Diamandis E.P. Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 54 July (1) (1997) 463-474
18. Ragolia L., Hall C.E., and Palaia T. Post-translational modification regulates prostaglandin D2 synthase apoptotic activity: characterization by site-directed mutagenesis. Prostaglandins Other Lipid Mediat 83 February (1-2) (2007) 25-32
19. Yoshikawa R., Wada J., Seiki K., et al. Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients. Diabetes Res Clin Pract 76 June (3) (2007) 358-367
20. Hirawa N., Uehara Y., Ikeda T., et al. Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus. Nephron 87 April (4) (2001) 321-327
21. Hamano K., Totsuka Y., Ajima M., et al. Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients. Nephron 92 September (1) (2002) 77-85
22. Ragolia L., Palaia T., Hall C.E., Maesaka J.K., Eguchi N., and Urade Y. Accelerated glucose intolerance, nephropathy, and atherosclerosis in prostaglandin D2 synthase knock-out mice. J Biol Chem 280 August (33) (2005) 29946-29955
23. Maesaka J.K., Palaia T., Frese L., Fishbane S., and Ragolia L. Prostaglandin D(2) synthase induces apoptosis in pig kidney LLC-PK1 cells. Kidney Int 60 November (5) (2001) 1692-1698
24. Ragolia L., and Begum N. The effect of modulating the glycogen-associated regulatory subunit of protein phosphatase-1 on insulin action in rat skeletal muscle cells. Endocrinology 138 June (6) (1997) 2398-2404
25. Eguchi N., Minami T., Shirafuji N., et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA 96 January (2) (1999) 726-730
26. Marshall S., Nadeau O., and Yamasaki K. Dynamic actions of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes: differential effects on glucosamine 6-phosphate, UDP-N-acetylglucosamine, and ATP levels. J Biol Chem 279 August (34) (2004) 35313-35319
27. Smith P.K., Krohn R.I., Hermanson G.T., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 October (1) (1985) 76-85
28. Khayat Z.A., Tong P., Yaworsky K., Bloch R.J., and Klip A. Insulin-induced actin filament remodeling colocalizes actin with phosphatidylinositol 3-kinase and GLUT4 in L6 myotubes. J Cell Sci 113 January (Pt 2) (2000) 279-290
29. Sui D., and Wilson J.E. Interaction of insulin-like growth factor binding protein-4, Miz-1, leptin, lipocalin-type prostaglandin D synthase, and granulin precursor with the N-terminal half of type III hexokinase. Arch Biochem Biophys 382 October (2) (2000) 262-274
30. Abel E.D. Myocardial insulin resistance and cardiac complications of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 5 June (2) (2005) 219-226
31. Abel E.D. Glucose transport in the heart. Front Biosci 9 January (2004) 201-215
32. Montessuit C., and Thorburn A. Transcriptional activation of the glucose transporter GLUT1 in ventricular cardiac myocytes by hypertrophic agonists. J Biol Chem 274 March (13) (1999) 9006-9012
33. Ragolia L., Palaia T., Paric E., and Maesaka J.K. Elevated L-PGDS activity contributes to PMA-induced apoptosis concomitant with downregulation of PI3-K. Am J Physiol Cell Physiol 284 January (1) (2003) C119-C126
34. Rosenblatt-Velin N., Lerch R., Papageorgiou I., and Montessuit C. Insulin resistance in adult cardiomyocytes undergoing dedifferentiation: role of GLUT4 expression and translocation. FASEB J 18 May (7) (2004) 872-874
35. Chen D., Huang Y., and Zhou K. Structure, localization and characterization of lipocalin-type prostaglandin D synthase. Zhonghua Nan Ke Xue 10 February (2) (2004) 134-138
36. Abel E.D., Kaulbach H.C., Tian R., et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest 104 December (12) (1999) 1703-1714
37. Castello A., Rodriguez-Manzaneque J.C., Camps M., et al. Perinatal hypothyroidism impairs the normal transition of GLUT4 and GLUT1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue. Evidence for tissue-specific regulation of GLUT4 expression by thyroid hormone. J Biol Chem 269 February (8) (1994) 5905-5912
38. Garcia-Fernandez L.F., Urade Y., Hayaishi O., Bernal J., and Munoz A. Identification of a thyroid hormone response element in the promoter region of the rat lipocalin-type prostaglandin D synthase (beta-trace) gene. Brain Res Mol Brain Res 55 April (2) (1998) 321-330
39. Wilson J.E. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206 June (Pt 12) (2003) 2049-2057
40. Fujimori K., Aritake K., and Urade Y. A novel pathway to enhance adipocyte differentiation of 3T3-L1 cells by up-regulation of lipocalin-type prostaglandin D synthase mediated by liver X receptor-activated sterol regulatory element-binding protein-1c. J Biol Chem 282 June (25) (2007) 18458-18466
41. Campbell S.E., and Febbraio M.A. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab 282 May (5) (2002) E1139-E1146
42. Barros R.P., Machado U.F., Warner M., and Gustafsson J.A. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci USA 103 January (5) (2006) 1605-1608